Sarissa Capital Management LP Portfolio Holdings
Sarissa Capital Management LP
- $572 Million
- Q1 2024
Sarissa Capital Management LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $572 Million distributed in 10 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ironwood Pharmaceuticals Inc with a value of $143M, Biogen Inc. with a value of $139M, Innoviva, Inc. with a value of $111M, Gilead Sciences, Inc. with a value of $80.8M, and Neurocrine Biosciences Inc with a value of $47.8M.
Examining the 13F form we can see an decrease of $77.3M in the current position value, from $649M to 572M.
Sarissa Capital Management LP is based out at Greenwich, CT
Below you can find more details about Sarissa Capital Management LP portfolio as well as his latest detailed transactions.